Tyra Biosciences Stock Market Value
| TYRA Stock | USD 29.19 0.81 2.70% |
| Symbol | Tyra |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tyra Biosciences. If investors know Tyra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Tyra Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Tyra Biosciences requires distinguishing between market price and book value, where the latter reflects Tyra's accounting equity. The concept of intrinsic value - what Tyra Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Tyra Biosciences' price substantially above or below its fundamental value.
Please note, there is a significant difference between Tyra Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tyra Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Tyra Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Tyra Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Tyra Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Tyra Biosciences.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Tyra Biosciences on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Tyra Biosciences or generate 0.0% return on investment in Tyra Biosciences over 90 days. Tyra Biosciences is related to or competes with Rezolute, Savara, Geron, Prime Medicine, Day One, Kura Oncology, and Maravai Lifesciences. Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor... More
Tyra Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Tyra Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Tyra Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.74 | |||
| Information Ratio | 0.2381 | |||
| Maximum Drawdown | 34.11 | |||
| Value At Risk | (4.26) | |||
| Potential Upside | 6.05 |
Tyra Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tyra Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Tyra Biosciences' standard deviation. In reality, there are many statistical measures that can use Tyra Biosciences historical prices to predict the future Tyra Biosciences' volatility.| Risk Adjusted Performance | 0.2158 | |||
| Jensen Alpha | 1.18 | |||
| Total Risk Alpha | 0.7688 | |||
| Sortino Ratio | 0.4013 | |||
| Treynor Ratio | (15.92) |
Tyra Biosciences February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2158 | |||
| Market Risk Adjusted Performance | (15.91) | |||
| Mean Deviation | 2.82 | |||
| Semi Deviation | 1.92 | |||
| Downside Deviation | 2.74 | |||
| Coefficient Of Variation | 391.27 | |||
| Standard Deviation | 4.62 | |||
| Variance | 21.37 | |||
| Information Ratio | 0.2381 | |||
| Jensen Alpha | 1.18 | |||
| Total Risk Alpha | 0.7688 | |||
| Sortino Ratio | 0.4013 | |||
| Treynor Ratio | (15.92) | |||
| Maximum Drawdown | 34.11 | |||
| Value At Risk | (4.26) | |||
| Potential Upside | 6.05 | |||
| Downside Variance | 7.52 | |||
| Semi Variance | 3.67 | |||
| Expected Short fall | (3.39) | |||
| Skewness | 2.84 | |||
| Kurtosis | 13.55 |
Tyra Biosciences Backtested Returns
Tyra Biosciences is not too volatile given 3 months investment horizon. Tyra Biosciences owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.23, which indicates the firm had a 0.23 % return per unit of risk over the last 3 months. We were able to interpolate data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.12% are justified by taking the suggested risk. Use Tyra Biosciences Risk Adjusted Performance of 0.2158, coefficient of variation of 391.27, and Semi Deviation of 1.92 to evaluate company specific risk that cannot be diversified away. Tyra Biosciences holds a performance score of 18 on a scale of zero to a hundred. The entity has a beta of -0.0736, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Tyra Biosciences are expected to decrease at a much lower rate. During the bear market, Tyra Biosciences is likely to outperform the market. Use Tyra Biosciences expected short fall, and the relationship between the value at risk and daily balance of power , to analyze future returns on Tyra Biosciences.
Auto-correlation | 0.79 |
Good predictability
Tyra Biosciences has good predictability. Overlapping area represents the amount of predictability between Tyra Biosciences time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Tyra Biosciences price movement. The serial correlation of 0.79 indicates that around 79.0% of current Tyra Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.79 | |
| Spearman Rank Test | 0.82 | |
| Residual Average | 0.0 | |
| Price Variance | 3.53 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Tyra Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tyra Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tyra Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tyra Biosciences Stock:Check out Tyra Biosciences Correlation, Tyra Biosciences Volatility and Tyra Biosciences Performance module to complement your research on Tyra Biosciences. For information on how to trade Tyra Stock refer to our How to Trade Tyra Stock guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Tyra Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.